UK markets closed

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.7900+0.2300 (+8.98%)
At close: 04:00PM EDT
2.8800 +0.09 (+3.23%)
After hours: 05:42PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-85,982
-59,084
-96,541
-128,790
-112,356
Depreciation & amortisation
441
391
578
-1,292
-1,067
Stock-based compensation
14,088
14,336
10,248
14,295
25,493
Change in working capital
37,969
-8,189
-20,286
-21,499
3,923
Accounts receivable
25,020
-21,785
-7,459
-11,228
4,440
Inventory
-17,800
-15,504
-11,760
-10,856
-
Other working capital
-27,188
-48,646
-103,800
-134,284
-81,239
Other non-cash items
6,326
4,273
1,518
3,241
2,721
Net cash provided by operating activities
-27,158
-48,273
-103,424
-134,045
-81,179
Cash flows from investing activities
Investments in property, plant and equipment
-30
-373
-376
-239
-60
Purchases of investments
-30,277
-15,117
-29,625
-102,207
-292,864
Sales/maturities of investments
0
20,000
122,500
237,000
165,050
Net cash used for investing activities
-30,307
4,510
92,499
134,554
-127,874
Cash flows from financing activities
Debt repayment
-
-319
-70,000
-
-
Common stock issued
21,077
18,392
21,891
26,559
51,517
Other financing activities
-
-397
-
-
-
Net cash used provided by (used for) financing activities
21,547
18,332
11,340
57,622
220,727
Net change in cash
-35,918
-25,431
415
58,131
11,674
Cash at beginning of period
75,548
106,048
105,633
47,502
35,828
Cash at end of period
39,630
80,617
106,048
105,633
47,502
Free cash flow
Operating cash flow
-27,158
-48,273
-103,424
-134,045
-81,179
Capital expenditure
-30
-373
-376
-239
-60
Free cash flow
-27,188
-48,646
-103,800
-134,284
-81,239